CEYIX
Price
$97.84
Change
-$0.78 (-0.79%)
Updated
Nov 13 closing price
Net Assets
5.27B
GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
Interact to see
Advertisement

CEYIX vs GFACX

Header iconCEYIX vs GFACX Comparison
Open Charts CEYIX vs GFACXBanner chart's image
Calvert Equity I
Price$97.84
Change-$0.78 (-0.79%)
VolumeN/A
Net Assets5.27B
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
CEYIX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
CEYIX vs. GFACX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEYIX is a StrongBuy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. CEYIX (5.27B). CEYIX pays higher dividends than GFACX: CEYIX (0.29) vs GFACX (0.00). CEYIX was incepted earlier than GFACX: CEYIX (26 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than CEYIX (0.65). GFACX is a more actively managed with annual turnover of: 25.00 vs. CEYIX (9.00). GFACX has a lower initial minimum investment than CEYIX: GFACX (250) vs CEYIX (1000000). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. CEYIX (-4.75). GFACX return over 5 years is better than : 27.87 vs. CEYIX (26.31).
CEYIXGFACXCEYIX / GFACX
Total Expense Ratio0.651.3648%
Annual Report Gross Expense Ratio0.651.3648%
Fund Existence26 years25 years-
Gain YTD5.48816.34334%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.27B340B2%
Annual Yield % from dividends0.290.00-
Returns for 1 year-4.754.61-103%
Returns for 3 years21.5156.1738%
Returns for 5 years26.3127.8794%
Returns for 10 years81.8875.78108%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics